-+ 0.00%
-+ 0.00%
-+ 0.00%

PRECIGEN RECEIVES FDA PLATFORM TECHNOLOGY DESIGNATION FOR ADENOVERSE PLATFORM

Reuters·09/21/2026 11:00:01

Please log in to view news